Houlihan Lokey, Inc. (HLI) Down 5.5% — Time to Cut My Losses Here?
Houlihan Lokey, Inc. (HLI) is struggling this Thursday, last trading at $145.67 on the NYSE — down $8.39 from the prior close of $154.06. The decline erases the prior session's gain and widens the stock's gap from its 52-week high of $195.06, set on January 21, 2026. HLI now trades about 25.3% below that level. The stock has given back roughly a quarter of its value in under ten months, even though the operating results in that period have mostly held up.
Turnover is light so far, with about 199,483 shares traded against a 90-day average of roughly 867,760. That is less than a quarter of normal daily volume. The selling has been steep but not yet heavy.
Why Houlihan Lokey, Inc. Price is Moving Lower
The most plausible driver is a broad selloff in investment-banking and advisory shares, not anything specific to Houlihan Lokey. Lazard (LAZ) was down about 5.2% and Evercore (EVR) was off 6.8% in morning trading, which puts HLI's decline in line with its closest advisory peers. The pressure reached the larger names as well. The Goldman Sachs Group, Inc. (GS) fell 6.67% and Blackstone Inc. (BX) dropped 4.67%, while the Financial Select Sector SPDR ETF (XLF) was down 1.45% in a morning update. The steeper losses among deal-driven firms suggest investors are pulling back from businesses whose revenue depends most on transaction activity.
The sector weakness came during a wider risk-off session. The S&P 500 fell 3.3%, the Nasdaq dropped 5%, and semiconductor shares slid 11%. In that kind of market, advisory stocks tend to be sold early because their fee income depends on CEO confidence, financing conditions, and steady equity markets. Profit-taking added to the decline: HLI had gained 4.99% on November 4, so Thursday's drop reverses that advance and then some.
The selling does not appear to reflect a problem with recent results. On October 28, Houlihan Lokey reported Q2 fiscal 2027 adjusted EPS of $1.85 against a $1.65 consensus, and revenue of $692 million against roughly $635 million expected. The details were less uniform than the headline beat:
Revenue rose 4.8% year over year, but net income attributable to HLI slipped 1.8% to $109 million from $111 million. Restructuring revenue fell 12% to $118 million. Corporate Finance revenue climbed 10%, even though completed deals in that segment dropped to 142 from 171. Management said it expects solid performance for the rest of the year but cautioned about external volatility, and Thursday's market is the kind of environment that warning described.
What is the Houlihan Lokey, Inc. Rating - Should I Sell?
Weiss Ratings assigns HLI a C rating. Current recommendation is Hold. The rating reflects a high-quality, well-capitalized advisory business whose stock has been a difficult holding over the past year. That combination argues for patience rather than either exiting or adding aggressively.
The operating profile is the strongest part of the case. The Excellent rating on the Efficiency Index is supported by a 17.27% return on equity and a 15.78% profit margin. Those are solid figures for an advisory firm whose largest expense is banker compensation, and they show the firm keeps meaningful profit even after paying its people. The Excellent Solvency Index rating fits a business model that does not require large balance-sheet commitments to generate fees. That financial cushion matters when deal markets turn unsettled, as they did Thursday.
Where the picture becomes more nuanced is growth and shareholder returns. The Fair rating on the Growth Index reflects revenue growth of 4.85% paired with a slight decline in net income. The most recent quarter also showed falling restructuring revenue and fewer completed Corporate Finance deals, a mix that keeps the Growth Index from rating higher. The Dividend Index is also rated Fair, consistent with a 1.77% yield that offers modest income without making HLI an income stock.
The weakest marks are on the Total Return Index and the Volatility Index, both rated Weak. A stock trading about 25% below its January peak has not rewarded recent holders. Thursday's sector-driven 5.45% drop, which followed a nearly 5% gain the day before, shows the sharp swings behind the Volatility rating. At a forward P/E of 24.63 against trailing EPS of $5.96, the valuation leaves little room for disappointment if deal activity slows.
Within the Financials sector, Houlihan Lokey is on par with The Goldman Sachs Group, Inc. (GS, C), Blackstone Inc. (BX, C), S&P Global Inc. (SPGI, C), and Berkshire Hathaway Inc. (BRKA, C). The uniform ratings across this group suggest that broader caution toward Financials is weighing on the sector as much as any company-specific factor.
About Houlihan Lokey, Inc.
Houlihan Lokey, Inc. (HLI) is a global investment bank in the Financials sector, headquartered in Los Angeles. It focuses on advisory work rather than lending or trading, serving corporations, financial sponsors, institutions and governments.
The business is organized into three segments. Corporate Finance, the largest, advises on mergers and acquisitions, capital markets transactions and private financing. The firm has built a particularly strong position in middle-market M&A, where it handles a high volume of mandates. Financial Restructuring advises debtors, creditors and other stakeholders on bankruptcies, out-of-court workouts and liability management, and it is one of the most established restructuring franchises in the industry. Financial and Valuation Advisory provides fairness opinions, solvency opinions, portfolio valuation work and dispute consulting, which brings in steady fees that depend less on market cycles.
The mix of segments is HLI's main structural advantage over more concentrated advisory firms. Restructuring work tends to rise when credit conditions worsen and M&A slows, which can partly offset weakness in Corporate Finance. The firm's deep relationships with private equity sponsors also provide repeat business across the full life of a portfolio company, from purchase through any restructuring to the eventual sale. These strengths do not make the firm immune to sharp drops in overall transaction activity, but they give it more balance than most of its advisory peers.
Investor Outlook
Houlihan Lokey (HLI) carries a Weiss Rating of C (Hold), and its strong efficiency and solvency are offset for now by a stock that remains well below its highs and sensitive to sector-wide swings. Investors should watch whether Corporate Finance deal counts recover from the drop to 142 completed transactions, and whether restructuring revenue stabilizes after its 12% decline. Management's caution about external volatility will be tested in the coming months. See full rankings of all C-rated Financials stocks inside the Weiss Stock Screener.
--